Chemours Co
CC- Exchange
- NYSE
- Industry
- Chemicals & Allied Products
- SEC CIK
- 0001627223
In the last 90 days, Chemours Co insiders filed 2 open-market purchases and 0 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $2.79B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:54 PM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 18, 2025 | Feb 29, 2024 | Feb 9, 2023 | Feb 10, 2022 |
| Revenue | $5.81B | $5.78B | $6.03B | $6.79B | $6.34B |
| Cost of revenue | $4.91B | $4.63B | $4.72B | $5.18B | $4.96B |
| Gross profit | $902.0M | $1.15B | $1.31B | $1.62B | $1.38B |
| Operating expenses | $966.0M | $810.0M | $1.55B | $844.0M | $705.0M |
| Research and development | $108.0M | $109.0M | $108.0M | $118.0M | $107.0M |
| Selling, general and administrative | $799.0M | $585.0M | $1.29B | $710.0M | $592.0M |
| Interest expense | $269.0M | $264.0M | $208.0M | $163.0M | $185.0M |
| Income tax | $109.0M | $41.0M | -$81.0M | $163.0M | $68.0M |
| Net income | -$386.0M | $86.0M | -$238.0M | $578.0M | $608.0M |
| EPS, basic | $-2.57 | $0.58 | $-1.60 | $3.72 | $3.69 |
| EPS, diluted | $-2.57 | $0.57 | $-1.60 | $3.65 | $3.60 |
| Weighted shares, basic | 150.2M | 149.5M | 148.9M | 155.4M | 164.9M |
| Weighted shares, diluted | 150.2M | 150.2M | 148.9M | 158.3M | 168.7M |
| Margins and growth | |||||
| Gross margin | 15.5% | 19.9% | 21.7% | 23.8% | 21.8% |
| Net margin | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% |
| Revenue growth, year over year | +0.4% | −4.1% | −11.3% | +7.1% | +27.7% |
| Net income growth, year over year | −548.8% | – | −141.2% | −4.9% | +177.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 18, 2025 | Feb 29, 2024 | Feb 9, 2023 | Feb 10, 2022 |
| Cash and equivalents | $670.0M | $713.0M | $1.20B | $1.10B | $1.45B |
| Accounts receivable | $562.0M | $619.0M | $509.0M | $509.0M | $644.0M |
| Inventory | $1.57B | $1.47B | $1.35B | $1.40B | $1.10B |
| Total current assets | $3.00B | $3.03B | $3.83B | $3.21B | $3.35B |
| Property, plant and equipment | $3.08B | $3.18B | $3.22B | $3.17B | $3.15B |
| Goodwill | $46.0M | $46.0M | $102.0M | $102.0M | $102.0M |
| Intangible assets | $2.00M | $3.00M | $3.00M | $13.0M | $6.00M |
| Total assets | $7.38B | $7.51B | $8.25B | $7.64B | $7.55B |
| Accounts payable | $954.0M | $1.14B | $1.16B | $1.25B | $1.16B |
| Short-term debt | $42.0M | $54.0M | $51.0M | $25.0M | $25.0M |
| Total current liabilities | $1.69B | $1.80B | $2.49B | $1.89B | $1.86B |
| Long-term debt | $4.10B | $4.05B | $3.99B | $3.59B | $3.72B |
| Total liabilities | $7.13B | $6.91B | $7.51B | $6.53B | $6.47B |
| Shareholders' equity | $251.0M | $605.0M | $739.0M | $1.11B | $1.08B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 18, 2025 | Feb 29, 2024 | Feb 9, 2023 | Feb 10, 2022 |
| Operating cash flow | $264.0M | -$633.0M | $556.0M | $754.0M | $820.0M |
| Capital expenditures | $213.0M | $360.0M | $370.0M | $307.0M | $277.0M |
| Free cash flow | $51.0M | -$993.0M | $186.0M | $447.0M | $543.0M |
| Depreciation and amortization | $340.0M | $301.0M | $307.0M | $291.0M | $317.0M |
| Stock-based compensation | $21.0M | $15.0M | $18.0M | $27.0M | $34.0M |
| Dividends paid | $78.0M | $148.0M | $149.0M | $154.0M | $164.0M |
| Share buybacks | – | – | $69.0M | $495.0M | $173.0M |
| Investing cash flow | -$206.0M | -$353.0M | -$229.0M | -$284.0M | $220.0M |
| Financing cash flow | -$126.0M | -$36.0M | $172.0M | -$685.0M | -$560.0M |
| Net change in cash | -$39.0M | -$1.04B | $503.0M | -$247.0M | $446.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.4% | 0.3% | 0.3% | 0.4% | 0.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 27, 2026 | 150.5M | +0.4% | SEC |
| Jul 30, 2026 | 150.5M | +0.5% | SEC |
| May 1, 2026 | 150.4M | +0.5% | SEC |
| Feb 18, 2026 | 150.1M | +0.4% | SEC |
| Oct 30, 2025 | 149.9M | +0.3% | SEC |
| Jul 30, 2025 | 149.7M | +0.3% | SEC |
| May 1, 2025 | 149.7M | +0.5% | SEC |
| Feb 12, 2025 | 149.4M | +0.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.